Back to Portfolio


Tumor analysis and classification platform

Lunaphore develops a platform using microfluidics to perform Immunohistochemistry (IHC). The microscopic assessment of biomarker patterns on tissues by IHC is a widely used diagnostic method in biology and personalized medicine to analyze tumors, neurological and other diseases. With Lunaphore’s solution, customers now benefit from unique workflow improvement and fast, highly accurate results at decreased costs.


Homepage Facebook Twitter  


Lunaphore in the News:

Knip, Trekksoft and Lunaphore among top 10 Swiss start-ups

Redalpine leads Series A round for revolutionary tissue diagnostics company Lunaphore


Jobs at Lunaphore